Clinical Trial

Research on Probiotics in Improving Obesity

Completed
View on ClinicalTrials.gov →
Summary
Assess the effects of Akkermansia muciniphila Akk11 heat - killed bacteria capsules compared to a placebo on body composition indicators (weight, BMI, body fat rate, waist - hip ratio (WC), wrist circumference, visceral fat area, basal metabolic rate) and blood lipid concentrations (total cholesterol (TC), low - density lipoprotein (LDL), high - density lipoprotein (HDL), triglycerides (TG)) in overweight/obese adults.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-07.
Status change: Recruiting → Completed 2026-01-27
Trial Details
NCT Number NCT06964919
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions Obesity
Enrollment 61 participants
Start Date 2025-03-10
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-01-20 (estimated)
Updated on ClinicalTrials.gov 2026-01-29